Healthcare | May 08, 2026
Vijaya Diagnostic Q4FY26 revenue jumps 27%, EBITDA margin expands to 43.5%
With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion
With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion
The company also announced a major portfolio shift, planning to divest its Immunodiagnostics business in China, a unit that generated approximately 6% of its fiscal 2025 revenue
The device is designed for early and accurate diagnosis of obstructive airway diseases such as COPD, and Asthma
Avio Smart Market Stack Limited and Huwel Lifesciences unveil portable, cost-efficient molecular testing platform
The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder
The transition from an outsourced MRI model to an in-house facility marks more than an infrastructure upgrade
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
Subscribe To Our Newsletter & Stay Updated
